
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
07/14/2025 | Q2 | -- | $6.3M | $0.29 | -- | -- |
04/10/2025 | Q1 | -- | $5.1M | -$0.01 | -- | -- |
11/30/2024 | Q4 | -- | $6.2M | $0.16 | -- | -- |
10/10/2024 | Q3 | -- | $5.9M | -$0.01 | -- | -- |
07/11/2024 | Q2 | -- | $6.7M | -$0.01 | -- | -- |
04/11/2024 | Q1 | -- | $5.7M | -$0.09 | -- | -- |
11/30/2023 | Q4 | -- | $6.9M | -$0.06 | -- | -- |
10/13/2023 | Q3 | -- | $8.1M | -$0.01 | -- | -- |
05/31/2023 | Q2 | -- | $8.2M | $0.06 | -- | -- |
02/28/2023 | Q1 | -- | $7.1M | $0.07 | -- | -- |
11/30/2022 | Q4 | -- | $6.6M | $0.02 | -- | -- |
08/31/2022 | Q3 | -- | $7.5M | $0.05 | -- | -- |
05/31/2022 | Q2 | -- | $7.3M | $0.04 | -- | -- |
02/28/2022 | Q1 | -- | $5.6M | -$0.09 | -- | -- |
11/30/2021 | Q4 | -- | $7.3M | $0.09 | -- | -- |
08/31/2021 | Q3 | -- | $6.6M | $0.01 | -- | -- |
05/31/2021 | Q2 | -- | $5.7M | $0.01 | -- | -- |
02/28/2021 | Q1 | -- | $5.4M | -$0.07 | -- | -- |
11/30/2020 | Q4 | -- | $5.5M | -$0.10 | -- | -- |
08/31/2020 | Q3 | -- | $6.5M | -$0.10 | -- | -- |
05/31/2020 | Q2 | -- | $5.4M | -$0.18 | -- | -- |
02/29/2020 | Q1 | -- | $5M | -$0.10 | -- | -- |
11/30/2019 | Q4 | -- | $7.5M | -$0.04 | -- | -- |
08/31/2019 | Q3 | -- | $5.5M | -$0.07 | -- | -- |
05/31/2019 | Q2 | -- | $5.7M | -$0.08 | -- | -- |
02/28/2019 | Q1 | -- | $4.1M | -$0.14 | -- | -- |
11/30/2018 | Q4 | -- | $3.8M | -$0.34 | -- | -- |
08/31/2018 | Q3 | -- | $5.3M | -$0.18 | -- | -- |
07/13/2018 | Q2 | -- | $5.3M | -$0.16 | -- | -- |
02/28/2018 | Q1 | -- | $5.4M | -$0.14 | -- | -- |
02/02/2018 | Q4 | -- | $5.1M | -$0.21 | -- | -- |
08/31/2017 | Q3 | -- | $6.5M | $0.01 | -- | -- |
07/14/2017 | Q2 | -- | $4.7M | -$0.12 | -- | -- |
04/12/2017 | Q1 | -- | $4.4M | -$0.06 | -- | -- |
02/02/2017 | Q4 | -- | $4.1M | -$0.14 | -- | -- |
10/06/2016 | Q3 | -- | $6.4M | -$0.07 | -- | -- |
07/18/2016 | Q2 | -- | $5.3M | -$0.02 | -- | -- |
04/14/2016 | Q1 | -- | $5.7M | $0.02 | -- | -- |
02/03/2016 | Q4 | -- | $5.7M | -$0.04 | -- | -- |
10/01/2015 | Q3 | -- | $6.5M | -$0.20 | -- | -- |
Art's-Way Manufacturing reported $6.3M worth of top line sales in its most recent quarter.
Art's-Way Manufacturing announced earnings per share of $0.29 which represents a beat of analyst forecast a -- per share.
Art's-Way Manufacturing reported $2.1M that represents $0.40 per share over the last quarter.
Art's-Way Manufacturing's earnings are forecast to grow from $0.06 per share to -- per share next year representing an increase of --.
Art's-Way Manufacturing's next earnings date is October 10, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.